Drug Profile
2-Camphanone
Alternative Names: AlphanonLatest Information Update: 22 Sep 2000
Price :
$50
*
At a glance
- Originator Bentley Pharmaceuticals
- Developer ALZA Corporation; Bentley Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Haemorrhoids
Most Recent Events
- 22 Sep 2000 Discontinued-I for Haemorrhoids in USA (Transdermal)
- 14 May 1998 Phase-I clinical trials for Haemorrhoids in USA (Transdermal)
- 15 Feb 1996 Belmac is now known as Bentley Pharmaceuticals